Skip to main content

Coronavirus: Vaccination

Question for Department of Health and Social Care

UIN 126896, tabled on 21 February 2022

To ask the Secretary of State for Health and Social Care, whether his Department plans for the Nuvaxovid vaccine to be available and distributed for use in the UK for the protection against covid-19.

Answered on

28 February 2022

On 3 February 2022, the Medicines and Healthcare products Regulatory Agency authorised Nuvaxovid (Novavax) for individuals over the age of 18 years old in the United Kingdom in line with official recommendations.

The Joint Committee on Vaccination and Immunisation (JCVI) will determine the potential for its use in the UK COVID-19 vaccination programme as the evidence becomes available in due course. Once the JCVI has considered the evidence, it will make an official recommendation to the Government.